Dose titration strategies represent an important consideration
According to reporting based on KFFs 2024 Employer Health Benefits Survey, fewer than 1 in 5 large firms (200+ employees) covered GLP-1 drugs for weight loss in 2024
There are no exceptions or shortcuts beyond state-specific telehealth registrations (like Floridas out-of-state provider option)
Presented for research literature review only Siegner R et al
Keywords Aging, GLP-1, GLP-1 RAs, Healthspan, Aging hallmarks, Geroscience, Inflammaging, Mitochondrail dysfunction, Autophagy, Neuroprotection, Public health Introduction Aging results from the interplay of genetic, environmental, and lifestyle factors operating within complex biological systems